Portfolio Companies


Microsources, Microspheres and Components for Radiotherapy

Operating Factories

Shareholders in Portfolio Company 
RUSNANO, Eckert & Ziegler BEBIG, NADEX MAX LTD, Santis

Industry Sector 
Innovative Nanobiopharmaceutics

Production Location 
Dubna, Moscow Oblast
Jobs to be created: 50

Investment Started:  2009

Total Budget

0.90  bln rubles
Co-investment by RUSNANO
0.71  bln rubles

Preparation and packaging of microsources for brachytherapy using isotope 125I. Production of nanostructured microspheres of amorphous material with isotope 90Y

Brachytherapy is a form of radiotherapy for malignant tumors in which the radiation source is placed within the affected organ. The optimal dose of radiation is delivered directly to the tumor without exposing adjacent tissues and organs. Brachytherapy is used extensively worldwide; it has been used in 800 medical centers in the United States and Western Europe for over 14 years.

This project will establish domestic production of microsources, titanium capsules containing a gold wire (x-ray marker) and radionuclide 125I (iodine-125) in the form of silver iodide whose surface has been modified for better ultrasound visualization. Portfolio company will also produce nanostructured microspheres of polymer, glass, or silicon particles that incorporate atoms of radioactive isotopes. Their diameters are about 30 microns.

Microsources produced by the project will be used to treat prostate, liver, and pancreatic cancers. Prostate cancer is one of the most common diseases in the country. There are more than 2.5 million cancer patients in Russia for whom effective treatment is essential. The project has high social significance.

Area of application

  • Medicine


  • Medical facilities and physicians treating patients with prostate cancer

Competitive advantages

  • Products without Russian analogue
  • Competitive price
  • Minimal side effects
  • Shorter hospital stays

Titanium capsules containing a gold wire (x-ray marker) and radionuclide 125I (iodine-125) in the form of silver iodide whose surface has been modified for better ultrasound visualization.